Still sees 2024 adjusted EBITDA $235.0M/$265.0M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on EVH: Evolent Announces First Quarter 2024 Results Evolent Health initiated with a Buy at Citi Evolent Health price target lowered to $44 from $45 at Canaccord